Barclays reiterates Overweight on ASML stock, EUR1,500 target

ASML raised full-year revenue guidance to EUR36-40 billion from EUR34-39 billion and reported strong Q1 2026 results, with net sales of EUR8.8 billion and a 53% gross margin. Barclays reiterated an Overweight rating and EUR1,500 price target, while ASML said order demand remains very strong and it can deliver at least 60 EUV low-NA units in 2026 and 80 in 2027 if demand holds. The outlook also incorporates potential export control updates, but the guidance and operational improvements are incrementally positive for the stock.

Analysis

ASML’s upside is less about the headline guidance bump and more about what it implies for industry capex discipline: if customers are locking in additional capacity now, the semicap equipment cycle has likely moved from “recovery” to “pre-build” mode. That tends to lift the whole supply chain, but the second-order winner is the high-purity materials / metrology stack, where pricing power usually lags the equipment OEM by 1-2 quarters and then accelerates as tool utilization rises.

The key margin lever is throughput, not just unit shipments. Each wafer-per-hour step-up on EUV low NA reduces the effective cost per good die and improves the ROI hurdle for foundries; that matters because it shortens payback periods on node transitions and can pull demand forward by 6-12 months. If the 1,000W source milestone proves durable, the market may begin to re-rate ASML more like a throughput-enabler than a pure backlog story, which supports a higher multiple — but also increases sensitivity to any execution slip.

The consensus seems to be underpricing export-control optionality. The guidance explicitly leaves room for policy changes, so the stock’s near-term path likely depends on headlines more than fundamentals: a benign policy backdrop could extend the multiple, while any incremental restriction would hit not just unit volumes but also the mix of the most profitable tools. That makes the next 4-8 weeks a catalyst-rich window rather than a straight-line compounding setup.

The contrarian risk is that the stock is already discounting a very clean capex upcycle and flawless execution. At current levels, upside from another guidance raise may be smaller than the downside from even a modest order normalization, especially if customers are pulling demand forward into 2026-27. In that sense, the better expression may be in relative value and options rather than outright long exposure.

Key Decisions for Investors

• Trim outright ASML long exposure into strength over the next 1-2 weeks; use any post-earnings/analyst upgrade pop to reduce beta, since the stock is already pricing a near-perfect execution path.
• Initiate a pair trade: long ASML vs short a basket of weaker semiconductor capital equipment names over 1-3 months, targeting relative outperformance if EUV throughput and capex momentum keep broadening.
• Buy medium-dated ASML call spreads into any 3-5% pullback, 3-6 month tenor, to capture upside from another guidance revision while capping premium burn if export-control headlines hit.
• Add exposure to semiconductor equipment suppliers with leverage to installed-base utilization and process control over 2-4 quarters; they should benefit from ASML-led tool adoption with lower headline risk.
• Set a hard risk trigger on ASML if export-control language tightens materially; that is the clearest catalyst to de-rate the name and would justify cutting longs quickly rather than waiting for fundamentals to roll over.